The decreased SIRT3 expression correlated strongly with an advanced T status and tumor stage (p < 0.001 and p = 0.013, respectively), suggesting that SIRT3 downregulation is intricately linked to more aggressive disease manifestations. Here, SIRT3 is linked to neoplasm.